NASP to Develop Pharmacy Practice Parameters for Specialty Pharmacy Therapeutic Categories
July 16th 2013The National Association of Specialty Pharmacy (NASP) announced it will begin developing pharmacy practice parameters in approximately 20 specialty pharmacy therapeutic categories this year.
Read More
Drug Approvals to Treat Neglected Diseases Have Nearly Doubled
July 12th 2013A new study released by the Tufts Center for the Study of Drug Development reports that annual drug approvals for neglected diseases have nearly doubled since 2000, and patient access to these therapies has improved markedly.
Read More
FDA Approves New Treatment for NSCLC in Patients with Certain EGFR Mutations
July 12th 2013The FDA today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test.
Read More
FDA Publishes Draft Guidance on Gene and Cell Therapy Clinical Trials
July 9th 2013Many of the types of drugs addressed by the guidance document could be categorized as specialty drugs because they require special handling, frequent dosing adjustments, and intensive clinical monitoring of adverse effects.
Read More
Pharmacy Times Grows Strategic Alliance Program With New Industry Partners
July 3rd 2013The pharmacy industry's No. 1 journal, Pharmacy Times, and its sister publication, Specialty Pharmacy Times, continue to add new industry-leading companies and organizations to their Strategic Alliance Partnership (SAP) programs.
Read More